384 related articles for article (PubMed ID: 30685333)
21. Microbial Etiology and Prognostic Factors of Ventilator-associated Pneumonia: A Multicenter Retrospective Study in Shanghai.
Huang Y; Jiao Y; Zhang J; Xu J; Cheng Q; Li Y; Liang S; Li H; Gong J; Zhu Y; Song L; Rong Z; Liu B; Jie Z; Sun S; Li P; Wang G; Qu J;
Clin Infect Dis; 2018 Nov; 67(suppl_2):S146-S152. PubMed ID: 30423049
[TBL] [Abstract][Full Text] [Related]
22. Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019.
Zilberberg MD; Nathanson BH; Puzniak LA; Shorr AF
Crit Care Med; 2022 Mar; 50(3):460-468. PubMed ID: 34534129
[TBL] [Abstract][Full Text] [Related]
23. Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Soubirou JF; Gault N; Alfaiate T; Lolom I; Tubach F; Andremont A; Lucet JC; Wolff M; Barbier F
Scand J Infect Dis; 2014 Mar; 46(3):215-20. PubMed ID: 24447250
[TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.
Oliva A; Liguori L; Covino S; Petrucci F; Cogliati-Dezza F; Curtolo A; Savelloni G; Comi M; Sacco F; Ceccarelli G; Viscido A; Alessandri F; Raponi G; Pugliese F; Mastroianni CM; Venditti M
Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1149-1160. PubMed ID: 38634975
[TBL] [Abstract][Full Text] [Related]
25. Impact of pathogen-directed antimicrobial therapy for ventilator-associated pneumonia in trauma patients on charges and recurrence.
Sharpe JP; Magnotti LJ; Weinberg JA; Swanson JM; Wood GC; Fabian TC; Croce MA
J Am Coll Surg; 2015 Apr; 220(4):489-95. PubMed ID: 25572796
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
[TBL] [Abstract][Full Text] [Related]
27. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
[No Abstract] [Full Text] [Related]
28. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
[TBL] [Abstract][Full Text] [Related]
29. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections.
Tabak YP; Sung AH; Ye G; Vankeepuram L; Gupta V; McCann E
J Hosp Infect; 2019 May; 102(1):37-44. PubMed ID: 30503367
[TBL] [Abstract][Full Text] [Related]
30. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.
Weber DJ; Rutala WA; Sickbert-Bennett EE; Samsa GP; Brown V; Niederman MS
Infect Control Hosp Epidemiol; 2007 Jul; 28(7):825-31. PubMed ID: 17564985
[TBL] [Abstract][Full Text] [Related]
31. [Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities].
Liu YN; Cao B; Wang H; Chen LA; She DY; Zhao TM; Liang ZX; Sun TY; Li YM; Tong ZH; Wang Z; He B; Yang W; Qu JM; Li XY; Chen RC; Ye F; Kang J; Li ER; Chen P; Zheng Y; Ma ZS; Ren J; Shi Y; Sun WK; Feng YL; Fan H; Jiang SJ; Zhang S; Xiong SD; Zuo P; Wang ZW
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):739-46. PubMed ID: 23289990
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of ventilator-associated pneumonia in a long-term acute care hospital.
Walkey AJ; Reardon CC; Sulis CA; Nace RN; Joyce-Brady M
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):319-24. PubMed ID: 19245314
[TBL] [Abstract][Full Text] [Related]
33. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia.
Luyt CE; Hékimian G; Koulenti D; Chastre J
Curr Opin Crit Care; 2018 Oct; 24(5):332-338. PubMed ID: 30036192
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study.
Guerci P; Bellut H; Mokhtari M; Gaudefroy J; Mongardon N; Charpentier C; Louis G; Tashk P; Dubost C; Ledochowski S; Kimmoun A; Godet T; Pottecher J; Lalot JM; Novy E; Hajage D; Bouglé A;
Crit Care; 2019 Nov; 23(1):371. PubMed ID: 31752976
[TBL] [Abstract][Full Text] [Related]
37. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
38. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
[TBL] [Abstract][Full Text] [Related]
39. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
[TBL] [Abstract][Full Text] [Related]
40. Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study.
Scholte JB; Zhou TL; Bergmans DC; Rohde GG; Winkens B; Van Dessel HA; Dormans TP; Linssen CF; Roekaerts PM; Savelkoul PH; van Mook WN
Infect Dis (Lond); 2016 Oct; 48(10):738-43. PubMed ID: 27207483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
